Retour sur lavenir.net
   SHURGARD 22.050 € (-3,29 %)     ACKERMANS V.HAAREN 269.600 € (-2,18 %)     KINEPOLIS GROUP 48.550 € (-2,02 %)     NYXOAH 1.336 € (-5,52 %)     ELIA GROUP 120.100 € (+0,67 %)     SOLVAY 25.840 € (-1,90 %)     KBC 131.050 € (-1,58 %)     ASCENCIO 52.800 € (-0,38 %)     ABO GROUP 3.760 € (-2,08 %)     FLUXYS BELGIUM D 22.500 € (+1,81 %)     AEDIFICA 66.200 € (-1,34 %)     BIOTALYS 2.140 € (-0,93 %)     AGEAS 73.800 € (-1,80 %)     AB INBEV 67.340 € (-2,07 %)     DEME GROUP 181.600 € (-0,55 %)     MELEXIS 65.900 € (-0,90 %)     SYENSQO 81.650 € (+0,80 %)     BEKAERT 38.150 € (-0,78 %)     DECEUNINCK 2.425 € (+0,41 %)     BANQUP GROUP 2.140 € (-7,36 %)     WDP 21.180 € (-1,12 %)     VIOHALCO 17.100 € (-1,50 %)     HOME INVEST BE. 18.560 € (-0,96 %)     IBA 15.280 € (-0,65 %)     VAN DE VELDE 30.100 € (0,00 %)     CIE BOIS SAUVAGE 300.000 € (-1,32 %)     UCB 204.600 € (-1,11 %)     EVS 28.550 € (-0,35 %)     OXURION 0.003 € (-7,14 %)     MONTEA 64.200 € (-1,83 %)     UMICORE 23.040 € (-0,17 %)     FAGRON 21.400 € (-0,93 %)     D'IETEREN GROUP 173.300 € (-0,46 %)     GIMV 44.550 € (-2,30 %)     PROXIMUS 6.240 € (-0,16 %)     KBC ANCORA 94.100 € (-1,16 %)     RECTICEL 12.720 € (-0,16 %)     ENERGYVISION 16.840 € (-0,36 %)     BREDERODE 103.600 € (-0,19 %)     VASTNED 28.400 € (-1,05 %)     GBL 75.050 € (-0,33 %)     LOTUS BAKERIES 12 140.000 € (-0,65 %)     RETAIL ESTATES 64.900 € (-1,52 %)     SOFINA 254.200 € (-1,63 %)     BPOST 1.248 € (-1,89 %)     CARE PROPERTY INV. 12.440 € (-0,80 %)     JENSEN-GROUP 75.400 € (+0,53 %)     CFE 11.000 € (-2,22 %)     VGP 74.200 € (-5,24 %)     COLRUYT 38.500 € (-1,84 %)     NYRSTAR 0.058 € (+4,69 %)     CENERGY 23.720 € (+2,15 %)     CMB.TECH 16.620 € (-0,12 %)     AGFA-GEVAERT 0.414 € (-0,36 %)     ARGENX SE 865.200 € (-0,07 %)     WERELDHAVE BELGIUM 50.400 € (-1,18 %)     AZELIS GROUP 12.130 € (-1,78 %)     TINC 11.040 € (-1,43 %)     TITAN S.A. 51.750 € (-1,52 %)     TUBIZE-FIN 175.700 € (-0,34 %)  
   PHILIPS KON 21.660 € (-0,91 %)     HAFFNER ENERGY 0.680 € (+8,11 %)     ASML HOLDING 1 497.600 € (-1,34 %)     ING GROEP N.V. 31.640 € (-1,88 %)     VINCI 111.800 € (-2,36 %)     VINPAI 2.920 € (+32,73 %)     EDENRED 28.590 € (-0,07 %)     ABC ARBITRAGE 5.250 € (0,00 %)     LVMH 411.250 € (-3,59 %)     BIOPHYTIS 0.068 € (-6,62 %)     LUMIBIRD 26.850 € (+6,34 %)     CSG 16.270 € (-2,98 %)     MICHELIN 33.760 € (-2,60 %)     ORANGE 15.215 € (-1,01 %)     RUBIS 34.140 € (-0,81 %)     AIR LIQUIDE 168.320 € (-2,80 %)     VEOLIA ENVIRON. 31.560 € (-1,22 %)     COMPAGNIE ODET 1 280.000 € (-2,44 %)     ESSILORLUXOTTICA 149.000 € (-0,40 %)     U10 CORP 1.370 € (+12,30 %)     HERMES INTL 1 409.000 € (-2,32 %)     SHELL PLC 40.940 € (+0,21 %)     NN GROUP 76.380 € (-3,68 %)     PUBLICIS GROUPE SA 96.040 € (-2,93 %)     JCDECAUX 24.000 € (+1,95 %)     ADYEN 951.600 € (-3,84 %)     COVIVIO 48.240 € (-1,59 %)     AHOLD DEL 30.960 € (-0,99 %)     CLARIANE 4.000 € (-1,19 %)     HOPIUM 0.004 € (-5,00 %)     ASM INTERNATIONAL 838.200 € (-0,36 %)     DASSAULT AVIATION 278.800 € (-0,92 %)     EUROPLASMA 0.001 € (-25,00 %)     THALES 225.700 € (-3,01 %)     ARGAN 72.100 € (-1,90 %)     SCHNEIDER ELECTRIC 289.700 € (-3,30 %)     GENFIT 12.300 € (-6,11 %)     BROADPEAK 2.300 € (-0,86 %)     2CRSI 28.440 € (-0,35 %)     JACQUET METALS 20.650 € (-2,59 %)     BE SEMICONDUCTOR 188.950 € (-3,20 %)     PERNOD RICARD 60.040 € (-1,12 %)     ATOS GROUP 25.760 € (-1,08 %)     EBUSCO HOLDING 0.217 € (-2,04 %)     STMICROELECTRONICS 44.625 € (-0,84 %)     RANDSTAD NV 37.710 € (+1,62 %)     SAINT GOBAIN 71.500 € (-3,90 %)     VERALLIA 18.960 € (-0,73 %)     ALSTOM 15.850 € (-2,88 %)     TIKEHAU CAPITAL 16.980 € (-0,35 %)     PHARMING GROUP 0.951 € (-2,04 %)     AMG 31.300 € (-2,37 %)     WORLDLINE 13.600 € (-4,21 %)     SPIE 43.720 € (-0,91 %)     POSTNL 0.887 € (-0,95 %)     GTT 218.800 € (-0,18 %)     AIR FRANCE -KLM 11.585 € (-1,66 %)     STELLANTIS NV 4.570 € (-2,10 %)     LISI 59.000 € (-2,32 %)     SOITEC 144.300 € (-1,40 %)  
News Réglementées
12/08/2026 16:05

RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine

EQS-News: RingConn; Ninenovo / Key word(s): Miscellaneous/Miscellaneous
RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine

12.08.2026 / 16:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


The study, "Large-scale bilateral cardiovascular monitoring via wearable rings," analyzes 97,559 valid ring-PPG samples from 1,810 participants, providing new insights into bilateral wearable sensing for cardiovascular monitoring.

NEW YORK, Aug. 12, 2026 /PRNewswire/ -- A major step toward overcoming long-standing accuracy bottlenecks in consumer wearables, a joint research team from Ninenovo (parent company of RingConn), Professor Cheng Chen's team at Shanghai Jiao Tong University, and Mianyang Central Hospital has published a new study in npj Digital Medicine, a Nature Portfolio journal, establishing what the researchers describe as the first large-scale bilateral ring-PPG benchmark. The study comprised 97,559 valid PPG samples from 1,810 participants, 7,478 paired blood pressure measurements, and found that combining synchronized PPG signals from both hands can substantially improve heart rate estimation, while also revealing important limitations in bilateral wearable approaches to blood pressure estimation and highlighting bilateral signal differences as a potential indicator of measurement reliability.

Cardiovascular disease remains one of the world's leading causes of death, making continuous and accessible cardiovascular monitoring an increasingly important area of health research. Photoplethysmography (PPG), a non-invasive optical sensing technology, has become a cornerstone of consumer wearables such as smartwatches and smart rings, enabling physiological signals to be captured continuously in everyday life. Yet most wearable PPG systems rely on measurements from a single location, typically one hand or one finger, implicitly assuming that signals collected from the left and right sides of the body are sufficiently consistent to be interchangeable. Whether this assumption holds true, however, has rarely been systematically investigated. This question became the starting point for a collaborative research effort involving academic, clinical, and industry partners to explore cardiovascular monitoring through bilateral ring-based PPG.

Analyzing 97,559 valid PPG samples, the study demonstrated that bilateral signals dramatically enhance measurement reliability. Synchronized dual-hand tracking reduced heart rate means absolute error (MAE) from 10.65 bpm (population baseline) down to 3.21 bpm, and further to 2.59 bpm when signal differences remained below defined thresholds. Furthermore, these performance gains proved consistent across 12 distinct AI model architectures. While blood pressure estimation improvements were more modest (systolic MAE improved from 13.81 to 12.36 mmHg; diastolic from 9.27 to 8.21 mmHg), the findings confirm that signal consistency and sensor placement are just as critical as raw data volume.

The study opens new possibilities for the evolution of wearable health technology. For Ninenovo and its flagship brand RingConn, this publication reinforces a shared commitment to advancing not only hardware, but also the underlying algorithms and data science of digital health. Through ongoing academic and clinical collaborations, Ninenovo continues to leverage cutting-edge research to transform raw physiological data into trustworthy, everyday health solutions.

*RingConn smart rings are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

About RingConn

Established in 2021, RingConn is a user-centric company, driven by continuous innovation, to provide professional, continuous, and thoughtful health monitoring products and services. RingConn is dedicated to becoming users' most trusted guardian for their physical and mental well-being.

About Ninenovo

As the parent company of RingConn, Ninenovo was founded by world-class scientists to empower human health through meaningful innovation. By integrating advanced technology into daily life, Ninenovo safeguards global well-being through RingConn.

Cision View original content:https://www.prnewswire.co.uk/news-releases/ringconn-advances-wearable-health-research-with-new-study-in-nature-portfolio-journal-npj-digital-medicine-302849687.html

rt.gif?NewsItemId=EN24817&Transmission_Id=202608121000PR_NEWS_EURO_ND__EN24817&DateId=20260812


12.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2381714  12.08.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière